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A B S T R A C T
P-glycoproteins (Pgps) are suspected to mediate drug extrusion in nematodes contributing to macrocy-
clic lactone resistance. This association was recently shown for Parascaris Pgp-11. Ivermectin resistance
was correlated with the presence of three pgp-11 single nucleotide polymorphisms and/or increased pgp-
11 mRNA levels. In the present study, the ability of Pgp-11 to modulate ivermectin susceptibility was
investigated by its expression in a pgp-11-deﬁcient Caenorhabditis elegans strain. Expression of Paras-
caris pgp-11 in two transgenic lines signiﬁcantly decreased ivermectin susceptibility in amotility (thrashing)
assay conducted in liquid medium. The EC50 values increased by 3.2- and 4.6-fold in the two lines rel-
ative to a transgenic control strain. This is the ﬁrst report on the successful functional analysis of a parasitic
nematode Pgp in the model organism C. elegans.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Infections with the gastrointestinal parasite Parascaris sp. have
a high pathogenic potential in foals and yearlings, leading occa-
sionally to severe diseases and even death (Cribb et al., 2006).
According to recent observations, the prevailing Parascaris species
appears unclear. Therefore, the relative prevalence of Parascaris
equorum and Parascaris univalens in horses is unknown (Jabbar et al.,
2014; Nielsen et al., 2014). These species are morphologically in-
distinguishable and to date can only be differentiated by karyotyping,
which was not feasible in the present study since material was col-
lected before publication of these reports. Therefore, throughout the
manuscript these parasites are referred to as Parascaris sp. Cur-
rently, most nematode-infected horses are treatedwith anthelmintics
belonging to the class of macrocyclic lactones (MLs) such as
ivermectin (IVM) (DiPietro et al., 1987). IVM was introduced into
the market in the early 1980s and has been widely used due to its
broad-spectrum activity. As a consequence, IVM resistance in Par-
ascaris sp. has been reported repeatedly worldwide (von
Samson-Himmelstjerna, 2012). The molecular mechanism of IVM
resistance in nematodes is under active investigation with evi-
dence suggesting polygenic mechanisms. These might be changes
in gene expression levels or frequencies of alleles of genes encoding
the drug target, i.e. glutamate-gated chloride channels (GluCls) (Kotze
et al., 2014).
The activity of P-glycoproteins (Pgps) has also received much at-
tention. These integral membrane proteins belong to the ABC-
transporter superfamily and contain two homologous halves, each
possessing six highly hydrophobic transmembrane helices. The
helices constitute the transport pathway and contain several amino
acid residues involved in substrate binding. The activity of these pro-
teins is ATP-dependent. Hydrolysis of ATP drives the transport of
endo- and exogenous Pgp substrates from the inner bilayer of the
plasma membrane to the extracellular compartment, which leads
to reduced drug concentration at the target site. Pgp substrates are
usually hydrophobic or amphiphilic and have molecular weights
between 330 and 4000 Da (Aller et al., 2009). Several MLs, espe-
cially IVM, interact with Pgps, as demonstrated in mammalian cell
lines overexpressing murine or human Pgp genes (Lespine et al.,
2007). Only recently, the expression of Haemonchus contortus Pgp-2
in mammalian cells was successful and its transport of MLs was de-
scribed (Godoy et al., 2015).
The heterologous expression of genes encoding parasitic nem-
atode Pgps in model nematodes such as Caenorhabditis elegans has
not been reported yet. C. elegans has been widely used as a model
for parasitic nematodes to screen for new drugs and to elucidate
themode of drug action (O’Reilly et al., 2014). Another option offered
by the C. elegans system is the generation of transgenic lines for
evaluating the function of genes from parasitic nematodes (Welz
et al., 2011; Miltsch et al., 2012), which can be accomplished either
by overexpression in the wild-type Bristol N2 strain or in strains
with a speciﬁc deletion of the C. elegans orthologue. C. elegans is par-
ticularly suitable for this kind of application because it is genetically
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and functionally well characterised. Previous studies have re-
ported a signiﬁcantly increased IVM susceptibility of strains with
a single Pgp loss-of-function mutation in a development assay
(Janssen et al., 2013b), particularly for a strain lacking an intact pgp-
11. Furthermore, its orthologue was implicated in IVM resistance
in Parascaris since pgp-11 was overexpressed in worms that did not
respond to IVM treatment, and three non-synonymous single nucleo-
tide polymorphisms (SNPs) within this gene correlated with
decreased IVM susceptibility (Janssen et al., 2013a).
In the present study, the potential impact of Pgp-11 on IVM sus-
ceptibility in Parascaris sp. was assessed by the functional expression
of Parascaris pgp-11 cDNA in a C. elegans pgp-11 loss-of-function
strain to evaluate its ability to modulate IVM resistance.
2. Materials and methods
2.1. Plasmid construction
To evaluate the impact of Parascaris Pgp-11 in IVM-susceptibility,
a plasmid containing the complete Parascaris pgp-11 cDNA under
control of a 3084 bp C. elegans pgp-11 promoter fragment up-
stream of the C. elegans pgp-11 start codon and the 735 bp C. elegans
3′-UTR of unc-54 downstream of the cDNA sequence was con-
structed (Fig. S1). A control plasmid lacked the Parascaris pgp-11
cDNA sequence. DNA was isolated from C. elegans for the construc-
tion of the expression plasmids using peqGOLD TriFast™ (Peqlab,
Erlangen, Germany) according to the manufacturer’s recommen-
dations. The Parascaris pgp–11 cDNA (accession-no.: JX308230)
sequence as found in IVM susceptible worms (Janssen et al., 2013a)
was ampliﬁed from a plasmid. Each region needed for plasmid con-
structionwas ampliﬁed in a PCR using gene-speciﬁc primers carrying
the required restriction sites in the 5′-regions for subsequent liga-
tion reactions. The PCRs were conducted in 50 μL reaction mixtures
using 0.5 μL of Phusion Hot Start II Polymerase (Thermo Scientif-
ic), 10 μL of 5 × Phusion HF buffer, 0.5 μM of each primer, 200 μM
dNTPs, and 35 ng genomic DNA (promoter and 3′-UTR) or 1 ng
plasmid DNA containing the pgp-11 cDNA. An initial denaturation
at 98 °C for 30 s was followed by 34 cycles of denaturation, anneal-
ing and extension according to the manufacturer’s instructions.
Speciﬁc annealing temperatures and extension times are provid-
ed in the supporting data (Table S1). The PCR products were cloned
into the pCR4®-Blunt vector (Life Technologies). Plasmid DNA of the
promoter and the 3′-UTR were digested with the corresponding re-
striction enzymes according to the manufacturer’s speciﬁcations
(Thermo Scientiﬁc). The linearised promoter and 3′-UTR frag-
ments were gel-puriﬁed and sub-cloned into the expression plasmid
upstream and downstream of the Parascaris pgp-11 sequence, re-
spectively, using T4 DNA ligase (Thermo Scientiﬁc). To generate a
control plasmid lacking the Parascaris pgp-11 sequence, this region
was removed by digesting the vector with ApaI and SﬁI. The vector
containing the C. elegans promoter and the 3′-UTR sequence was iso-
lated by gel electrophoresis. Before re-ligation with T4 DNA ligase
(Thermo Scientiﬁc), the polymerase/exonuclease activities of Phusion
Hot Start II DNA polymerase (Thermo Scientiﬁc) were used to gen-
erate a blunt-end product. All plasmids were sequenced by GATC
Biotech (Konstanz, Germany) to ensure that no mutations were in-
troduced during the PCR and that the ligation sites were complete.
2.2. Transformation of tm0333
The mutant C. elegans strain deﬁcient in pgp-11 (tm0333) was
maintained under standard conditions. Plasmids for the expres-
sion of Parascaris pgp-11 and the control plasmid were diluted in
water and injected into the germline of young adult C. elegans her-
maphrodites at a concentration of 50 ng/μL as described previously
(Miltsch et al., 2012). A plasmid carrying a pharyngeal gfp-expression
marker (pPD118.33, Addgene plasmid 1596: L3790) was co-
injected as a transformationmarker at a concentration of 25 ng/μL.
Successfully transformed worms were identiﬁed by GFP ﬂuores-
cence and isolated on newagar plates. Transcription of the complete
sequenceof Parascarispgp-11was conﬁrmedbyRT-PCRusingprimers
and PCR conditions as described elsewhere (Janssen et al., 2013a).
2.3. Thrashing assay
A thrashing assay was conducted to evaluate the impact of Par-
ascaris Pgp-11 for IVM-susceptibility. Young adult transgenic
individuals were selected, transferred to individual wells of a
48-well plate and incubated in the dark under constant shaking
(150 rpm) in S-Medium containing various IVM-concentrations (0,
1, 2.5, 5, 7.5, and 10 nM; Sigma-Aldrich, 18898; IVM B1a ≥ 90%, IVM
B1b ≤ 5%) at 20 °C for 18 h. IVMwas dissolved in dimethyl sulphoxide
(DMSO) and diluted with water to a ﬁnal DMSO concentration of
1%. Escherichia coli OP50 was available as a food source. The worms
were then transferred to a well with the corresponding medium
(same IVM concentration without food) and allowed to adapt to light
for 1 min before movement was quantiﬁed under an inverse mi-
croscope by counting the number of body bends for 1 min. Each
concentration was replicated at least three times on four separate
days (n ≥ 12 for each concentration). The number of movements was
normalised to the mean of the no-drug control of the same trans-
genic line to obtain relative motility in per cent. Regression curves
were calculated using four-parameter logistic regression in GraphPad
Prism 5.0 with the top and bottom values constrained to values
between 0 and 100%. EC50 values were compared using the extra
sum-of-squares F-test implemented in the software. P values < 0.05
were considered to be statistically signiﬁcant.
3. Results and discussion
Two transgenic lines were produced by injection with the Par-
ascaris pgp-11 expression plasmid (Cel-pgp-11::Parascaris-pgp-
11(1) and Cel-pgp-11::Parascaris-pgp-11(2)), and another line was
obtained after injectionwith the control plasmid (Cel-pgp-11::control).
All lines showed semi-stable transmission of gfp expression, with
transmission rates between 45 and 84% (Fig. S2). Transmission rates
varied between lines but were apparently constant within the lines
since no obvious changes in the frequency of gfp-positive larvae in
the progeny of transgenic hermaphrodites were observed. However,
exact determination of transmission rates was performed only once
shortly after establishing the lines. No obvious variability of ﬂuo-
rescence intensity was observed between gfp-positive individuals
of the same line (Fig. S2). Only individuals with gfp expression in
the pharynx were used for further investigation. A RT-PCR target-
ing the full-length sequence conﬁrmed expression of Parascaris pgp-
11 mRNA in both transgenic lines (Fig. S3).
A statistically signiﬁcant increase (P < 0.0001) in the IVM EC50
value was observed in the thrashing assay for both lines injected
with the Parascaris pgp-11 expression construct, Cel-pgp-
11::Parascaris-pgp-11(1) and Cel-pgp-11::Parascaris-pgp-11(2), relative
to the control line Cel-pgp-11::control (Table 1 and Fig. 1). The EC50
values were increased by approximately 4.6- and 3.2-fold in the two
expression constructs.
These results and data from earlier surveys strongly suggest a
participation of Pgp-11 in IVM-susceptibility (Janssen et al., 2013b).
The use of the pgp-11-deﬁcient C. elegans strain tm0333 was thus
appropriate in the present experiment involving the expression of
the Parascaris orthologue to address its function in IVM suscepti-
bility. The overall identity between the amino acid sequences of these
two species is 37% (Janssen et al., 2013a). In the ﬁrst and second
transmembrane domains, 30% and 28% identity was observed,
whereas identities of 56% and60%were found for theﬁrst and second
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nucleotide-binding domain, which are in general more highly con-
served. Transformation of well-known model organisms such as
C. elegans is often the only technically feasible option for examin-
inggene function inparasiticnematodes, sinceprotocols for successful
maintenance of transformed parasitic nematodes have not been de-
veloped yet. Accordingly, they are rarely accessible for forward or
reverse geneticmethods (Gilleard, 2013),mostly due to their complex
life cycles that cannot be completely reproduced in vitro. C. elegans
is often the expression systemof choice for genes of parasitic nema-
todes. Functional rescues analysing anthelmintic eﬃcacy inC. elegans
have been conductedwithß-tubulin- andGluClα-deﬁcientC. elegans
strains using orthologues from H. contortus (Kwa et al., 1995;
Glendinning et al., 2011), with slo-1-deﬁcient strains containing
orthologues fromAncylostoma caninum andCooperia oncophora (Welz
et al., 2011), andwith an unc-49-deﬁcient strain expressing the Toxo-
cara canis unc-49b cDNA (Miltsch et al., 2012).
In the present study, this type of assay was successfully used to
investigate the impact of Parascaris Pgp-11 on IVM susceptibility
and decreased IVM susceptibility in a pgp-11 loss-of-function strain
of C. elegans. Modulation of IVM susceptibility by the injected
transgenewas assessed in a thrashing assay, revealing signiﬁcantly
increased EC50 values for both transgenic lines in comparison to the
control line. The 3.2- and 4.6-fold increases in the EC50 values were
similar to the 3.8-fold increase obtained in a development assay com-
paring the pgp-11 loss-of-function strainwithN2wild-typeC. elegans
(Janssen et al., 2013b) but it should be stressed that changes in EC50
values cannot bedirectly comparedbetweendifferent types of assays.
As within each generation a fraction of the transgenic individuals
loses the transgene, it is diﬃcult to conduct a development assay
with lines carrying extra-chromosomal transgenes. For that reason,
a thrashing assaywas performedwhich uses individualworms iden-
tiﬁed as transgenic due to gfp-expression and not populations of
ca. 100worms as statistical unit. In comparison to body-bend assays
conducted on agar plates, worms move more rapidly in thrashing
assays (Miller et al., 1996) resulting in a broader dynamic range of
the assay. In addition, a liquid medium as it was used here, prob-
ably allows amore reproducible and homogenous IVM-distribution
than an agar-based medium.
ABC transporters are known for their multi-drug-resistance ac-
tivity in eukaryotes and prokaryotes. They are able to mediate
transport in both directions in prokaryotic cells, but only act as ex-
porters from the cytosolic compartment in eukaryotes (Davidson
et al., 2008). Several nematode Pgps have been suspected to be in-
volved in resistance to IVM. Apart from one functional study using
a recombinant Pgp (Godoy et al., 2015), most of the records are de-
scriptive and report changes in expression levels or frequency of
alleles. Only a few Pgps appear to be of particular importance for
IVM detoxiﬁcation and the development of resistance. For example,
increased expression in ML-resistant isolates has been reported for
pgp-9 in Teladorsagia circumcincta and H. contortus and for pgp-2 in
H. contortus (Dicker et al., 2011; Williamson et al., 2011). Further-
more, pgp-11 was expressed at higher levels in an IVM-resistant
isolate of C. oncophora (De Graef et al., 2013). Comparable results
were obtained for pgp-1 of Onchocerca volvulus (Huang and Prichard,
1999), which is in fact an orthologue of C. elegans pgp-11 (Ardelli
and Prichard, 2013). Very recently, Godoy et al. (2015) and Kaschny
et al. (2015) have shown that recombinant H. contortus Pgp-2 and
Cylicocyclus elongatus Pgp-9 interact directly with MLs and that the
intensity of interaction depends on the particular ML.
The decrease in susceptibility observed in the transgenic C. elegans
model system clearly demonstrates that Parascaris Pgp-11 can con-
tribute to the response to treatment with IVM. Nevertheless, this
increase on its own, even if it occurs at a similar level in Parascaris
sp., might not be high enough to entirely account for the pheno-
typically apparent IVM resistance levels observed in Parascaris
populations in the ﬁeld or in trichostrongyloid species of sheep
(Demeler et al., 2013). The combined effects of changes in several
paralogues, however, may produce higher resistance levels. Con-
sidering the genetic background encoding 13 additional, functional
Pgps, and assuming that different Pgps have overlapping substrate
spectra, an increase in the EC50 value of more than 4.6-fold prob-
ably cannot be expected.
In the future, the three SNPs within Parascaris pgp-11 that have
been correlated with an IVM resistance phenotype (Janssen et al.,
2013a) should be analysed regarding their individual effects on IVM
susceptibility. For this approach, the MosSCI recombination system
is an eﬃcient tool to insert transgenes into deﬁned chromosomal
locations. This method is suitable to eliminate confounding effects
of transgene transmission to the next generation, copy number, and
integration-site dependant differences in expression levels
(Frokjaer-Jensen et al., 2008).
Table 1
Effect of Parascaris pgp-11 expression on ivermectin susceptibility in Caenorhabditis elegans pgp-11 deﬁcient background (strain tm0333) recorded by measurement of in-
dividual motility (body bends).
Line Cel-pgp-11::control Cel-pgp-11::Parascaris-pgp-11(1) Cel-pgp-11::Parascaris-pgp-11(2)
EC50a [μM] (95% CIb) 1.095 (0.96–1.24) 5.033 (4.71–5.38) 3.523 (2.97–4.18)
R2 0.7469 0.7978 0.676
P – <0.0001 <0.0001
Fold change of EC50 value from control line – 4.6 3.2
a EC50, 50% effective concentration.
b CI, conﬁdence interval.
Fig. 1. Concentration–response curves to ivermectin of the control and Parascaris
pgp-11 transgenic Caenorhabditis elegans in a pgp-11-deﬁcient genetic background
(tm0333). After incubation for 18 h in a medium containing various concentrations
of ivermectin or only the vehicle DMSO (1%), the motilities of C. elegans worms were
recorded for 1min in liquid medium containing the same drug concentration. Trans-
genic lines were produced by transformation with pgp-11 expression constructs
(Cel-pgp-11::Parascaris-pgp-11(1) (triangle), Cel-pgp-11::Parascaris-pgp-11(2) (square))
or the construct lacking the pgp-11 cDNA (Cel-pgp-11::control (circles)). The motil-
ity of single worms was assessed as body bends per minute. The negative control
without IVM was set to 10−11M to allow log10 transformation of the concentra-
tions. Values represent means ± standard error of the mean of at least 12 worms.
The bottom and top values for four-parameter logistic regression were constrained
to values between 0 and 100%.
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To our knowledge this is the ﬁrst report on the successful func-
tional analysis of a parasitic nematode Pgp in the model organism
C. elegans. The results described in this study provide an impor-
tant insight into the impact of a single Pgp from a parasitic nematode
in the mechanism of IVM detoxiﬁcation. The current C. elegans ex-
pression system still has relevant limitations, but it allows the
functional analysis of genes associated with anthelmintic resis-
tance in amodel organism resembling parasitic nematodes as closely
as currently possible.
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